Treatment destinations and visit frequencies for patients seeking medical treatment overseas from the United Arab Emirates: results from Dubai Health Authority reporting during 2009–2016
Tóm tắt
Each year, the Dubai Health Authority (DHA) spends millions of dollars to cover the costs of United Arab Emirates (UAE) nationals seeking healthcare overseas. Patients may travel overseas to seek an array of treatments. It is important to analyze the number of trips and treatment destinations for patients travelling overseas to provide baseline information for the DHA to improve polices and strategies related to overseas treatment for UAE nationals. Administrative data were obtained from the DHA for UAE nationals who sought medical treatment overseas during 2009–2016. We examined the number of trips and treatment destinations by medical specialty, age, gender, years of travel and travel seasons. Multinomial logistic and negative binomial regression models were used to assess the relationships of the treatment destinations and number of trips, respectively, with the key variables of interest. The study included data from 6557 UAE nationals. The top three treatment destinations were Germany (46%), the UK (19%) and Thailand (14%). The most common medical specialties were orthopedic surgery (13%), oncology (13%) and neurosurgery (10%). Oncology had the highest expected number of trips adjusted for a number of covariates (IRR 1.34, 95% CI: 1.24–1.44). Regarding destination variation, patients had a lower relative risk ratio of seeking healthcare in Germany in the winter (RRR 0.68, 95% CI: 0.57–0.80). Endocrinology was the most common medical specialty sought in the UK (RRR 3.36, 95% CI: 2.01–5.60). This is the first study to systematically examine the current practice of medical treatment overseas among UAE nationals. The results demonstrate that treatment destinations, medical specialties for which treatment was sought, age, gender and travel season are significant factors in understanding overseas travel for medical care. The study can guide the DHA in collecting more data for further research that may lead to policy-relevant information about sending patients to the best-quality treatment choices at an optimal cost.
Tài liệu tham khảo
Burkett L. Medical tourism. Concerns, benefits, and the American legal perspective. J Leg Med. 2007;28(2):223–45.
Chanda R. Trade in health services; 2002.
Eissler LA, Casken J. Seeking health care through international medical tourism. J Nurs Scholarsh. 2013;45(2):177–84.
Forgione DA, Smith PC. Medical tourism and its impact on the US health care system. J Health Care Finance. 2007;34(1):27–35.
Henson JN, Guy BS, Dotson MJ. Should I stay or should I go?: motivators, decision factors, and information sources influencing those predisposed to medical tourism. Int J Healthc Manag. 2015;8(1):4–14.
Smith PC, Forgione DA. Global outsourcing of healthcare: a medical tourism decision model. Journal of Information Technology Case and Application Research. 2007;9(3):19–30.
Lunt N, Horsfall D, Hanefeld J. Medical tourism: a snapshot of evidence on treatment abroad. Maturitas. 2016;88:37–44.
Dubai Annual Health Statistical Reports of 2009–2016, Dubai, 2016–2017.
Dubai health authority. Insurance system for advancing healthcare in Duabi. 2014.
Koornneef EJ, Robben PB, Al Seiari MB, Al Siksek Z. Health system reform in the emirate of Abu Dhabi, United Arab Emirates. Health policy. 2012;108(2–3):115–21.
The official portal of the UAE government. Travelling abroad for medical treatment 2019.
GULF NEWS. Lack of speciality hospitals forcing Emiratis to travel abroad. 2018.
United Arab Emirates Ministry of Health & prevention. Request treatment abroad. 2019.
McCallum BT, Jacoby P. Medical outsourcing: Reducing clients’ health care risks. J Financial Planning. 2007;20(10):60–9.
Cohen IG. How to regulate medical tourism (and why it matters for bioethics). Developing world bioethics. 2012;12(1):9–20.
Cohen IG. Patients with passports: medical tourism, law, and ethics. New York, NY: Oxford University Press; 2014.
Crooks VA, Turner L, Cohen IG, Bristeir J, Snyder J, Casey V, et al. Ethical and legal implications of the risks of medical tourism for patients: a qualitative study of Canadian health and safety representatives’ perspectives. BMJ Open. 2013;3:e002302. https://doi.org/10.1136/bmjopen-2012-002302.
Turner LG. Quality in health care and globalization of health services: accreditation and regulatory oversight of medical tourism companies. Int J Qual Health Care. 2011;23(1):1–7.
Thompson CB. Descriptive data analysis. Air Med J. 2009;28(2):56–9.
Youngquist ST. Part 19: what is a P value? Air Med J. 2012;31(2):56–71.
Curtis K, Youngquist ST. Part 21: categoric analysis: Pearson chi-square test. Air medical journal. 2013;32(4):179–80.
Thorpe RJ Jr, Gamaldo AA, Salas RE, Gamaldo CE, Whitfield KE. Relationship between physical function and sleep quality in African Americans. J Clin Sleep Med. 2016;12(10):1323.
Aw TC. Global public health and the United Arab Emirates. Asia Pac J Public Health. 2010;22(3 Suppl):19S–24S.
Loney T, Aw TC, Handysides DG, Ali R, Blair I, Grivna M, et al. An analysis of the health status of the United Arab Emirates: the 'Big 4′ public health issues. Glob Health Action. 2013;6:20100.
Mokdad AH, Jaber S, Aziz MI, AlBuhairan F, AlGhaithi A, AlHamad NM, et al. The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014;383(9914):309–20.
Rahim HF, Sibai A, Khader Y, Hwalla N, Fadhil I, Alsiyabi H, et al. Non-communicable diseases in the Arab world. Lancet. 2014;383(9914):356–67.
Gan LL, Frederick JR. Medical tourists: who goes and what motivates them? Health Mark Q. 2013;30(2):177–94.
Guy BS, Henson JLN, Dotson MJ. Characteristics of consumers likely and unlikely to participate in medical tourism. Int J Healthc Manag. 2015;8(2):68–76.
Heung VC, Kucukusta D, Song H. A conceptual model of medical tourism: implications for future research. J Travel Tour Mark. 2010;27(3):236–51.
Kozak M. Comparative analysis of tourist motivations by nationality and destinations. Tour Manag. 2002;23(3):221–32.
Turnbull DR, Uysal M. An exploratory study of German visitors to the Caribbean: push and pull motivations. J Travel Tour Mark. 1995;4(2):85–92.
Yu JY, Ko TG. A cross-cultural study of perceptions of medical tourism among Chinese, Japanese and Korean tourists in Korea. Tour Manag. 2012;33(1):80–8.
Al-Hinai SS, Al-Busaidi AS, Al-Busaidi IH. Medical tourism abroad: a new challenge to Oman's health system - Al Dakhilya region experience. Sultan Qaboos Univ Med J. 2011;11(4):477–84.
Johnston R, Crooks VA, Snyder J, Kingsbury P. What is known about the effects of medical tourism in destination and departure countries? A scoping review. Int J Equity Health. 2010;9:24.
Crooks VA, Kingsbury P, Snyder J, Johnston R. What is known about the patient's experience of medical tourism? A scoping review. BMC Health Serv Res. 2010;10(1):266.
Lunt N, Carrera P. Medical tourism: assessing the evidence on treatment abroad. Maturitas. 2010;66(1):27–32.
Yeoh E, Othman K, Ahmad H. Understanding medical tourists: word-of-mouth and viral marketing as potent marketing tools. Tour Manag. 2013;34:196–201.
Al-Darmaki FR, Hassane S, Ahammed S, Abdullah AS. Developing counselor education identity in UAE: evaluation of an undergraduate program. J Int Counselor Educ. 2012;4(1):1.
Baeesa SS, Maghrabi Y, Msaddi AK, Assaker R. Quality of spine surgery research from the Arab countries: A Systematic review and bibliometric analysis. Biomed Res Int 2017:7560236.
Zafar S, Badsha H, Mofti A, Delosantos A, Altares J, Matudio G, et al. Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis. J Clin Rheumatol. 2012;18(6):279–82.
Moufarrej MN, Mahfoud Z, Badsha H. Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study. Rheumatol Int. 2015;35(4):759–63.
Halabi H, Alarfaj A, Alawneh K, Alballa S, Alsaeid K, Badsha H, et al. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East. Int J Rheum Dis. 2015;18(3):268–75.
Badsha H, Kong KO, Tak PP. Rheumatoid arthritis in the United Arab Emirates. Clin Rheumatol. 2008;27(6):739–42.
El Zorkany B, et al. Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? 2013. p. 151–9.
Al-Sharhan GOTM. Genetic disorders in the Arab world: United Arab Emirates: cancers in the United Arab Emirates; 1985.
Khoja T, Zahrani A, Khoja TAM. Epidemiology of cancer in the Gulf region. Pan Arab J Oncology. 2010;3(1):8–10.
Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A, et al. Cancer epidemiology and control in the Arab world - past, present and future. Asian Pac J Cancer Prev. 2009;10(1):3–16.
Emirates TMoHUA. Cancer incidence in united arab emirates annual report of the uae - national cancer registry - 2014.
El Helal TA, Bener A, Galadari I. Pattern of cancer in the United Arab Emirates referred to AL-Ain hospital. Annals of Saudi medicine. 1997;17:506–9.
Al-Maskari F, El-Sadig M, Norman JN. The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates. Cardiovasc Diabetol. 2007;6:24.
Al-Maskari F, El-Sadig M. Prevalence of risk factors for diabetic foot complications. BMC Fam Pract. 2007;8:59.
Al-Maskari F, El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol. 2007;7:11.
Sheikh-Ismail LI, et al. Prevalence of overweight and obesity among adult females in the United Arab Emirates. Int J Food Sci Nutr. 2009;60(sup3):26–33.
Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.
Alwan A, Maclean DR, Riley LM, d'Espaignet ET, Mathers CD, Stevens GA, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376(9755):1861–8.
Solomon DJ, et al. Evaluation and implementation of public health registries. Public Health Rep. 1991;106(2):142.
Atkins D. Creating and synthesizing evidence with decision makers in mind: integrating evidence from clinical trials and other study designs. Med Care. 2007;45(10 Supl 2):S16–22.
Chalkidou K, Whicher D, Kary W, Tunis S. Comparative effectiveness research priorities: identifying critical gaps in evidence for clinical and health policy decision making. Int J Technol Assess Health Care. 2009;25(3):241–8.
Kurbasic I, Pandza H, Masic I, Huseinagic S, Tandir S, Alicajic F, et al. The advantages and limitations of international classification of diseases, injuries and causes of death from aspect of existing health care system of Bosnia and Herzegovina. Acta Inform Med. 2008;16(3):159–61.
Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009;151(3):203–5.
Benner JS, Morrison MR, Karnes EK, Kocot SL, McClellan M. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps. Health Aff (Millwood). 2010;29(10):1768–76.
Clancy CM. Getting to ‘smart’health care. Health Aff. 2006;25(6):w589–w92.
Comparative Effectiveness Research: The Need for a Uniform Standard [Internet]. 2009.
Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008;118(3):309–18.
Lauer MS, Collins FS. Using science to improve the nation's health system: NIH’s commitment to comparative effectiveness research. JAMA. 2010;303(21):2182–3.
Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S, Chronic Disease Action G. Prevention of chronic diseases: a call to action. Lancet. 2007;370(9605):2152–7.
Del Giudice ME, et al. Primary care physicians' views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(20):3338–45.